Get the Stockscreener App
8.13
0.85%
-0.07
Fennec Pharmaceuticals Inc stock is traded at $8.13, with a volume of 44,214.
It is down -0.85% in the last 24 hours and down -17.71% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$8.20
Open:
$8.24
24h Volume:
44,214
Relative Volume:
0.60
Market Cap:
$226.92M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-13.33
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
-7.82%
1M Performance:
-17.71%
6M Performance:
+29.05%
1Y Performance:
+87.33%
1-Day Range:
$8.03
$8.32
1-Week Range:
$8.03
$9.16
52-Week Range:
$3.96
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.13 | 228.22M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
Does Fennec Pharmaceuticals Inc. stock trade at a discount to peersJuly 2025 Closing Moves & Technical Pattern Recognition Alerts - newser.com
Can Fennec Pharmaceuticals Inc. (RV41) stock withstand sector downturnsInsider Selling & Technical Pattern Based Buy Signals - newser.com
Is Fennec Pharmaceuticals Inc. stock attractive for hedge fundsWeekly Stock Analysis & Safe Capital Investment Plans - newser.com
Is Fennec Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Market Overview & Community Consensus Picks - newser.com
Will Fennec Pharmaceuticals Inc. (RV41) stock outperform Dow JonesInflation Watch & Risk Adjusted Swing Trade Ideas - newser.com
How to integrate Fennec Pharmaceuticals Inc. into portfolio analysis toolsEarnings Performance Report & Stepwise Entry and Exit Trade Signals - newser.com
How Fennec Pharmaceuticals Inc. (RV41) stock trades in high volatilityNew Guidance & Safe Entry Momentum Tips - newser.com
Can momentum traders help lift Fennec Pharmaceuticals Inc.Trade Analysis Report & Risk Controlled Daily Trade Plans - newser.com
Will a bounce in Fennec Pharmaceuticals Inc. offer an exitJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
What hedge fund moves indicate for Fennec Pharmaceuticals Inc. (RV41) stock2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
What is the fair value estimate for Fennec Pharmaceuticals Inc. (RV41) stock in 2025Weekly Gains Summary & Community Verified Swing Trade Signals - newser.com
Can Fennec Pharmaceuticals Inc. stock withstand economic slowdownEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Can Fennec Pharmaceuticals Inc. stock maintain growth trajectory2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
What MACD and RSI say about Fennec Pharmaceuticals Inc.July 2025 Market Mood & High Yield Stock Recommendations - newser.com
Developing predictive dashboards with Fennec Pharmaceuticals Inc. data2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
How resilient is Fennec Pharmaceuticals Inc. stock in market downturns2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Is Fennec Pharmaceuticals Inc. (RV41) stock cheap by valuation metricsTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Using portfolio simulators with Fennec Pharmaceuticals Inc. includedTrade Signal Summary & Entry Point Strategy Guides - newser.com
Is Fennec Pharmaceuticals Inc. stock a top pick in earnings seasonDollar Strength & Growth Focused Investment Plans - newser.com
Is Fennec Pharmaceuticals Inc. stock ready for breakoutTrade Volume Summary & High Conviction Buy Zone Alerts - newser.com
Identifying reversal signals in Fennec Pharmaceuticals Inc.2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Why Fennec Pharmaceuticals Inc. stock remains undervaluedProduct Launch & Free Community Supported Trade Ideas - newser.com
How buyback programs support Fennec Pharmaceuticals Inc. (RV41) stockWeekly Market Summary & Safe Capital Allocation Plans - newser.com
Fennec Pharmaceuticals Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50 Day Moving AverageTime to Sell? - MarketBeat
Will earnings trigger a reversal in Fennec Pharmaceuticals Inc.Take Profit & Weekly High Conviction Trade Ideas - newser.com
Can Fennec Pharmaceuticals Inc. (RV41) stock sustain double digit ROEEarnings Miss & Low Drawdown Trading Techniques - newser.com
Reversal indicators forming on Fennec Pharmaceuticals Inc. stockEarnings Recap Summary & Consistent Income Trade Ideas - newser.com
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fennec Pharmaceuticals Inc Stock (FENC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A | Director |
Oct 10 '25 |
Sale |
9.24 |
1,775 |
16,401 |
57,079 |
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):